Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 ResultsWe included 349 patients with a mean age of 58.08

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Frontiers in Cardiovascular Medicine

MARCH 6, 2025

Case 2 was a 79-year-old man with a history of hypertension and coronary heart disease who presented with gradually worsening fatigue lasting 6h. Coronary angiography showed mild, non-obstructive atherosclerosis in the dominant left circumflex artery (LCx), which continued along the anatomical course of the RCA.

Congenital 52

Congenital Pacemaker Myocardial Infarction Atherosclerosis 52

Cardiometabolic Health Congress

JANUARY 15, 2025

The Hidden Threat: SMuRFless Myocardial Infarctions A concerning trend in CVD is the increase in myocardial infarctions (MI) among individuals without standard modifiable risk factors (SMuRFless MI).

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Objectives There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). vs. 8.9%, p  = 0.009) but a lower rate of hypertension (46.8% Results The mean age of participants was 65.4 years, and 75.0% mg/dl (16.3%

Stents 64

Stents Stent Myocardial Infarction Outcomes 64

Hypertension Journal

FEBRUARY 22, 2024

Hypertension, Ahead of Print. In modeling, the risk for any cardiovascular disease event among women with a history of hypertensive disorders of pregnancy was generally 10% to 20% higher, with main models estimating hazard ratios to 1.20 (95% CI, 0.99–1.47) years for women with type 1 and 29.8 years for women with type 2 diabetes.

Cardiovascular Disease 74

Cardiovascular Disease Hypertension Diabetes Myocardial Infarction 74

Open Heart

MARCH 3, 2025

Of these, 2079 (1286 DP-DES and 793 BP-DES) met the inclusion and exclusion criteria and completed a 2-year follow-up: The primary outcome was the device-oriented composite endpoint (DOCE) of cardiac death, non-fatal target vessel myocardial infarction and target lesion revascularisation. Results Mean age was 67 years, with 75% male.

Stents 52

Stents Stent Myocardial Infarction Angioplasty 52

Frontiers in Cardiovascular Medicine

JANUARY 22, 2024

This observation has not been investigated in hypertensives of African ancestry. We hypothesised that an individual patient data meta-analysis (IPD-MA) on the efficacy of second- or third-generation beta-blockers (STGBBs) in hypertensives of African descent may provide new insights. 3.00; P < 0.001) in hypertensive Africans.

Blood Pressure 64

Blood Pressure Hypertension Myocardial Infarction Cardiovascular Disease 64

Journal of Cardiovascular Pharmacology

APRIL 4, 2024

Myocardial infarction (MI) and pulmonary artery hypertension (PAH) are two prevalent cardiovascular diseases. This study aims to evaluate the effect of PTE on oxidative stress in the hearts of animals with myocardial infarction and in the lungs of animals with PAH. Male Wistar rats were used in both models.

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Disease Pulmonary Hypertension 40

Circulation

NOVEMBER 11, 2024

Background:Pulmonary hypertension (PH) is a major contributor to cardiovascular disease-related morbidity and mortality. Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Hospital Hypertension Pulmonary 40

Hypertension Journal

DECEMBER 19, 2023

Hypertension, Ahead of Print. Hypertension affects &gt;1 billion people worldwide. Complications of hypertension include stroke, renal failure, cardiac hypertrophy, myocardial infarction, and cardiac failure. Instead, we propose that hypertension can only be truly managed by precision.

Hypertension 45

Hypertension Myocardial Infarction Strokes Stroke 45

Heart BMJ

APRIL 25, 2024

Objective Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovascular disease (CVD) risk profiles later in life. We investigated whether genetic liability to pre-eclampsia/eclampsia and gestational hypertension is associated with CVD risk factors and occurrence of CVD events.

Cardiovascular Disease 52

Cardiovascular Disease Hypertension Blood Pressure Myocardial Infarction 52

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

American College of Cardiology

NOVEMBER 13, 2024

He then explores complete vs. culprit-only revascularization in older patients with myocardial infarction (MI) with or without ST-segment elevation. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves.

Bicuspid/Mitral 62

Bicuspid/Mitral Myocardial Infarction Hypertension Outcomes 62

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. 2.71]) or hypertensive emergency (odds ratio, 1.46 [95% CI, 1.00–2.14]) Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction COVID-19 Medicare Hospital 40

Circulation

NOVEMBER 11, 2024

eGC shedding could contribute to atherosclerotic plaque vulnerability and acute myocardial infarction (AMI) installation. The integrity of this structure sustains some vascular properties such as shear stress-induced nitric oxide release and the prevention of platelets and neutrophils adhesion on the vessel surface. The PBR [1.96±0.22µm

Myocardial Infarction 40

Myocardial Infarction Plaque Technology Diabetes 40

Circulation

NOVEMBER 11, 2024

This study investigates the relationship between baseline 5-HTP levels and the incidence of major adverse cardiovascular events (MACE) in patients who have experienced ST-elevation myocardial infarction (STEMI).Objective:Our years, 53 women) followed for up to 15 years.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Bypass Graft STEMI Angina 40

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. They had significantly lower rates of diabetes and hypertension and higher rates of male gender and smoking compared to the older group.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Coronary Artery Disease Journal

APRIL 24, 2024

Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction STEMI Diabetes Hypertension 40

American College of Cardiology

AUGUST 26, 2024

What is the relationship of subendocardial perfusion with cardiac injury, structure, and a composite of major adverse cardiovascular and cerebral events (MACCE) consisting of death, heart failure (HF) hospitalization, myocardial infarction, and stroke?

Myocardial Infarction 42

Myocardial Infarction Hypertension Heart Failure Hospital 42

Journal of Cardiovascular Pharmacology

JANUARY 14, 2024

Pretreatment with an oral P2Y12 receptor blocker (before coronary angiography) vs. treatment in the catheterization laboratory has been a matter of debate in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI). The pretreatment group included 232 patients, and the no-pretreatment group included 87 patients.

Myocardial Infarction 40

Myocardial Infarction Catheterization Laboratory Laboratory Hypertension 40

European Journal of Heart Failure

DECEMBER 18, 2024

Covariates were adjusted for age (years), pulmonary congestion, percutaneous coronary intervention, left ventricular ejection fraction (%) and hypertension.

Myocardial Infarction 40

Myocardial Infarction BMI Outcomes Heart Failure 40

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Journal of the American Heart Association

DECEMBER 29, 2023

We compared the risk of adverse events between hypertensive patients using valsartan and a propensity score–matched group using nonrecalled angiotensin receptor blockers and angiotensin‐converting enzyme inhibitors.Methods and ResultsWe used Optum's deidentified Clinformatics Datamart (July 2017–January 2019).

Hypertension 45

Hypertension Myocardial Infarction Hospital Heart Failure 45

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

The overall prevalence of arterial hypertension was 33.2%, hyperlipidemia, 26.9%, smoking, 17.8%, and diabetes, 3.9%. of the patients were diagnosed with non-ST elevated myocardial infarction (NSTEMI), 36.8% The overall mean age was 49.12 +/− 3.41, and 88% were females. Approximately 48.5%

SCAD 75

SCAD Coronary Artery Bypass Graft Outcomes Myocardial Infarction 75

Circulation

NOVEMBER 11, 2024

The primary outcome was a composite of the incidence of myocardial infarction and ischemic and hemorrhagic stroke, obtained by tracking the medical use data of the first-ever ICD-10 codes. Dyslipidemia and HTN were the most dominant risk factors for myocardial infarction and stroke, respectively.

Myocardial Infarction 40

Myocardial Infarction Hypertension Cardiovascular Disease Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 1, 2024

The pooled risks for overall response rate (ORR), 1-year progression-free survival (PFS), adverse events (AEs), immune-related AEs, (irAEs), hypertension, and vascular events defined as stroke, myocardial infarction and pulmonary embolisms, were calculated. 2.97) and PFS (HR 0.49, 95% CI: 0.39–0.63)

Myocardial Infarction 64

Myocardial Infarction Hypertension Embolism Pulmonary 64

Dr. Smith's ECG Blog

APRIL 14, 2024

A 56 year old male with PMHx significant for hypertension had chest pain for several hours, then presented to the ED in the middle of the night. So we know there is myocardial infarction and the patient has persistent pain, but it is very mild. The pain was located in the mid to left chest and developed after riding his bike.

Chest Pain 120

Chest Pain Ischemia Myocardial Infarction Ultrasound 120

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

This is a value typical for a large subacute MI, n ormal value 48 hours after myocardial infarction is associated with Post-Infarction Regional Pericarditis ( PIRP ). Mechanical complications secondary to myocardial infarction are infrequent due to most patients receiving revascularization quite rapidly.

Cardiogenic Shock 110

Cardiogenic Shock Chest Pain Pericarditis Myocardial Infarction 110

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Journal of the American Heart Association

MARCH 13, 2025

The CRHCP (China Rural Hypertension Control Project) trial demonstrated that intensive BP control reduces cardiovascular events. The primary outcome of major adverse cardiovascular events included stroke, myocardial infarction, heart failure, and death from cardiovascular causes, during a 3year followup.

Blood Pressure 40

Blood Pressure Cardiovascular Disease Myocardial Infarction Hypertension 40

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. Smith's ECG Blog

JUNE 27, 2021

A 50-something man with history only of alcohol abuse and hypertension (not on meds) presented with sudden left chest pain, sharp, radiating down left arm, cramping, that waxes and wanes but never goes completely away. Angiogram: "ACS - Non ST Elevation Myocardial Infarction. This is a HUGE myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction Ischemia STEMI Pulmonary 40

Dr. Smith's ECG Blog

APRIL 22, 2024

A 50-something male with hypertension and 20- to 40-year smoking history presented with 1 week of stuttering chest pain that is worse with exertion, which takes many minutes to resolve after resting and never occurs at rest. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction.

Chest Pain 119

Chest Pain Myocardial Infarction Anatomy Angina 119

DAIC

MARCH 21, 2024

Impella Left Sided Blood Pumps also are used when there is ongoing cardiogenic shock that occurs less than 48 hours after a severe heart attack (acute myocardial infarction), open-heart surgery, or when the heart is not functioning well due to a condition called cardiomyopathy.

Cardiogenic Shock 104

Cardiogenic Shock Open-Heart Surgery Myocardial Infarction Heart attacks 104

Dr. Smith's ECG Blog

MAY 20, 2024

A 63 year old man with a history of hypertension, hyperlipidemia, prediabetes, and a family history of CAD developed chest pain, shortness of breath, and diaphoresis after consuming a large meal at noon. He called EMS, who arrived on scene about two hours after the onset of pain to find him hypertensive at 220 systolic. Murakami MM.

Chest Pain 127

Chest Pain Blood Pressure Ischemia STEMI 127

Open Heart

JUNE 5, 2024

Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1% vs 9.9%, p=0.029).

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Circulation

OCTOBER 13, 2023

BACKGROUND:Apparent treatment-resistant hypertension (aTRH) is prevalent and associated with adverse outcomes in heart failure with mildly reduced or preserved ejection fraction. Nonresistant hypertension was defined as BP above threshold but not meeting aTRH criteria. per 100 patient-years) compared with nonresistant hypertension (2.7

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Hypertension Myocardial Infarction 40